You are here: Industry Insights > cancer therapeutics

News List

Ascentage Pharma and MD Anderson Cancer Center Announce Strategic Alliance in Cancer Drug Development pharmafocusasia
January 09, 2019
Ascentage Pharma Group, Inc., and The University of Texas MD Anderson Cancer Center today announced a five-year strategic collaboration agreement to advance the development of five potential new cancer therapies.....
GSK to acquire cancer therapeutics firm Tesaro for $5.1bn pharmaceutical-technology
December 05, 2018
GlaxoSmithKline (GSK) has signed a merger agreement to buy US-based biopharmaceutical company Tesaro for an aggregate consideration of around $5.1bn in a cash-based transaction......
Selvita to Present New Data from SEL120 Program at EORTC-NCI-AACR Symposium on Molecular Targets and Cancer Therapeutics b3cnewswire
November 10, 2018
The presentation during the symposium will feature preclinical data from Selvita’s CDK8 inhibitor program SEL120 - potential treatment of acute myeloid and lymphoblastic leukemias. SEL120 is the most advanced, fully-owned oncology program in company’s pip
Selvita to Present New Data from SEL120 Program at EORTC-NCI-AACR Symposium on Molecular Targets and Cancer Therapeutics b3cnewswire
November 10, 2018
The presentation during the symposium will feature preclinical data from Selvita’s CDK8 inhibitor program SEL120 - potential treatment of acute myeloid and lymphoblastic leukemias. SEL120 is the most advanced, fully-owned oncology program in company’s pip
Affimed signs up to $5bn cancer therapeutics deal with Genentech pharmaceutical
August 30, 2018
German biopharmaceutical firm Affimed has signed a collaboration agreement with Roche unit Genentech to develop and commercialise immunotherapeutics targeting a variety of cancers.